CELLULAR BIOMEDICINE GROUP, INC. Increase (Decrease) in Deferred Revenue
CELLULAR BIOMEDICINE GROUP, INC. reported Increase (Decrease) in Deferred Revenue of $0 for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2019-11-06
- CELLULAR BIOMEDICINE GROUP, INC. increase (decrease) in deferred revenue for the quarter ending 2019-09-30 was $0.00.
- CELLULAR BIOMEDICINE GROUP, INC. increase (decrease) in deferred revenue for the quarter ending 2018-09-30 was -$7.60K.
- CELLULAR BIOMEDICINE GROUP, INC. increase (decrease) in deferred revenue for the quarter ending 2017-09-30 was -$559.10K.
- CELLULAR BIOMEDICINE GROUP, INC. increase (decrease) in deferred revenue for the quarter ending 2016-09-30 was $0.00.
- CELLULAR BIOMEDICINE GROUP, INC. increase (decrease) in deferred revenue for fiscal 2013 was -$251.83K.
- CELLULAR BIOMEDICINE GROUP, INC. increase (decrease) in deferred revenue for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
- CELLULAR BIOMEDICINE GROUP, INC. increase (decrease) in deferred revenue for fiscal 2011 was $41.23K, a 68.67% decline from fiscal 2010.
- CELLULAR BIOMEDICINE GROUP, INC. increase (decrease) in deferred revenue for fiscal 2010 was $131.60K.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month | Increase (Decrease) in Deferred Revenue 12 month as first filed |
|---|---|---|---|---|---|
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $0.00 10-Q · filed 2019-11-06 | |||
| 2019-06-30 | $0.00 10-Q · filed 2019-08-06 | ||||
| 2018-09-30 | -$7.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$12.11K 10-Q · filed 2019-11-06 | |||
| 2018-06-30 | -$4.51K 10-Q · filed 2019-08-06 | ||||
| 2017-09-30 | -$559.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $510.42K 10-Q · filed 2018-11-06 | |||
| 2017-06-30 | $1.07M 10-Q · filed 2018-08-07 | ||||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $0.00 10-Q · filed 2017-11-08 | |||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-08 | ||||
| 2013-12-31 | -$158.85K derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-13 | -$251.83K 10-K · filed 2015-04-13 | |||
| 2013-09-30 | -$92.98K 10-Q · filed 2014-11-19 | ||||
| 2012-12-31 | -$2.49M derived: 10-K 12 month − 10-Q 9 month · filed 2014-04-15 | $124.27K derived: sum of 2 quarters · filed 2014-04-15 | -$20.00K derived: sum of 3 quarters · filed 2014-04-15 | $0.00 10-K · filed 2014-04-15 | -$124.27K 10-K · filed 2013-04-04 |
| 2012-09-30 | $2.61M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-09 | $2.47M derived: sum of 2 quarters · filed 2012-11-09 | $2.49M 10-Q · filed 2012-11-09 | $2.50M derived: sum of 4 quarters · filed 2013-08-14 | |
| 2012-06-30 | -$144.27K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-22 | -$124.27K 10-Q/A · filed 2012-08-22 | -$114.23K derived: sum of 3 quarters · filed 2013-08-14 | -$83.04K derived: sum of 4 quarters · filed 2013-08-14 | |
| 2012-03-31 | $20.00K 10-Q · filed 2012-05-15 | $30.04K derived: sum of 2 quarters · filed 2013-08-14 | $61.23K derived: sum of 3 quarters · filed 2013-08-14 | ||
| 2011-12-31 | $10.04K derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-08-14 | $41.23K derived: sum of 2 quarters · filed 2013-08-14 | $41.23K 10-K/A · filed 2013-08-14 | ||
| 2011-09-30 | $31.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $31.20K 10-Q · filed 2012-11-09 | |||
| 2011-06-30 | $0.00 10-Q · filed 2011-08-15 | ||||
| 2010-12-31 | -$9.37K derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-08-14 | $23.64K derived: sum of 2 quarters · filed 2013-08-14 | $131.60K 10-K/A · filed 2013-08-14 | ||
| 2010-09-30 | $33.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $140.97K 10-Q · filed 2011-11-14 | |||
| 2010-06-30 | $107.96K 10-Q · filed 2011-08-15 |